Zhu and colleagues showed, in a murine breast cancer model, that CXCR3 acts both on the tumor and host compartments by promoting metastasis and impairing the host’s anti-tumor immunity, and that both could be improved through chemical and genetic approaches to CXCR3 inhibition [42]. The gene discussed is CXCR3; the disease is neoplasm.